13D RE INHALE THERAPEUTIC SYSTEMS

Company

NEKTAR THERAPEUTICS

Filed

February 18, 1997

Accession Number

0000921530-97-000054

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →